- Home
- INFU vs VOR Comparison
INFU vs VOR Comparison
Compare INFU & VOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INFU
- VOR
- Stock Information
- Founded
- INFU 2005
- VOR 2015
- Country
- INFU United States
- VOR United States
- Employees
- INFU N/A
- VOR N/A
- Industry
- INFU Medical/Dental Instruments
- VOR Biotechnology: Pharmaceutical Preparations
- Sector
- INFU Health Care
- VOR Health Care
- Exchange
- INFU Nasdaq
- VOR Nasdaq
- Market Cap
- INFU 180.4M
- VOR 207.1M
- IPO Year
- INFU N/A
- VOR 2021
- Fundamental
- Price
- INFU $10.36
- VOR $24.11
- Analyst Decision
- INFU Strong Buy
- VOR Buy
- Analyst Count
- INFU 2
- VOR 6
- Target Price
- INFU $13.50
- VOR $84.00
- AVG Volume (30 Days)
- INFU 185.4K
- VOR 430.1K
- Earning Date
- INFU 11-04-2025
- VOR 11-07-2025
- Dividend Yield
- INFU N/A
- VOR N/A
- EPS Growth
- INFU 2168.02
- VOR N/A
- EPS
- INFU 0.24
- VOR N/A
- Revenue
- INFU $139,886,000.00
- VOR N/A
- Revenue This Year
- INFU $9.02
- VOR N/A
- Revenue Next Year
- INFU $6.73
- VOR N/A
- P/E Ratio
- INFU $43.65
- VOR N/A
- Revenue Growth
- INFU 8.13
- VOR N/A
- 52 Week Low
- INFU $4.61
- VOR $2.62
- 52 Week High
- INFU $11.04
- VOR $65.80
- Technical
- Relative Strength Index (RSI)
- INFU 57.28
- VOR 41.32
- Support Level
- INFU $9.96
- VOR $23.12
- Resistance Level
- INFU $10.87
- VOR $28.66
- Average True Range (ATR)
- INFU 0.44
- VOR 2.35
- MACD
- INFU 0.07
- VOR -1.28
- Stochastic Oscillator
- INFU 73.44
- VOR 9.61
About INFU InfuSystems Holdings Inc.
InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. INFU services are provided under a two-reportable segment. The first is Patient Services, providing the last-mile solution for clinic-to-home healthcare where the continuing treatment involves complex durable medical equipment and services. The Patient segment is comprised of Oncology, Pain Management and Wound Therapy businesses. The second, Device Solutions, supports the Patient Services platform and leverages service orientation to win incremental business from its direct payer clients. The Device segment is comprised of direct payer rentals, pump and consumable sales, and biomedical services and repair. Majority from Patient.
About VOR Vor Biopharma Inc.
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.